Bank of America’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $156M | Buy |
|
|||||
|
2025
Q1 | $120M | Sell |
|
|||||
|
2024
Q4 | $152M | Sell |
|
|||||
|
2024
Q3 | $193M | Buy |
|
|||||
|
2024
Q2 | $201M | Buy |
|
|||||
|
2024
Q1 | $241M | Buy |
|
|||||
|
2023
Q4 | $174M | Sell |
|
|||||
|
2023
Q3 | $154M | Buy |
|
|||||
|
2023
Q2 | $162M | Buy |
|
|||||
|
2023
Q1 | $142M | Buy |
|
|||||
|
2022
Q4 | $146M | Buy |
|
|||||
|
2022
Q3 | $123M | Buy |
|
|||||
|
2022
Q2 | $107M | Sell |
|
|||||
|
2022
Q1 | $144M | Sell |
|
|||||
|
2021
Q4 | $201M | Sell |
|
|||||
|
2021
Q3 | $237M | Sell |
|
|||||
|
2021
Q2 | $223M | Buy |
|
|||||
|
2021
Q1 | $150M | Buy |
|
|||||
|
2020
Q4 | $102M | Sell |
|
|||||
|
2020
Q3 | $94.3M | Buy |
|
|||||
|
2020
Q2 | $61.4M | Buy |
|
|||||
|
2020
Q1 | $42.6M | Sell |
|
|||||
|
2019
Q4 | $74M | Sell |
|
|||||
|
2019
Q3 | $66.3M | Buy |
|
|||||
|
2019
Q2 | $67M | Buy |
|
|||||
|
2019
Q1 | $65.2M | Sell |
|
|||||
|
2018
Q4 | $55.8M | Sell |
|
|||||
|
2018
Q3 | $71.2M | Sell |
|
|||||
|
2018
Q2 | $60.6M | Sell |
|
|||||
|
2018
Q1 | $58.2M | Buy |
|
|||||
|
2017
Q4 | $49.3M | Sell |
|
|||||
|
2017
Q3 | $69.3M | Buy |
|
|||||
|
2017
Q2 | $56.1M | Sell |
|
|||||
|
2017
Q1 | $52.5M | Buy |
|
|||||
|
2016
Q4 | $42.3M | Sell |
|
|||||
|
2016
Q3 | $67.6M | Sell |
|
|||||
|
2016
Q2 | $83.2M | Buy |
|
|||||
|
2016
Q1 | $43.8M | Buy |
|
|||||
|
2015
Q4 | $41.5M | Buy |
|
|||||
|
2015
Q3 | $11.6M | Buy |
|
|||||
|
2015
Q2 | $2.6M | Sell |
|
|||||
|
2015
Q1 | $4.82M | Sell |
|
|||||
|
2014
Q4 | $3.88M | Buy |
|
|||||
|
2014
Q3 | $1.76M | Buy |
|
|||||
|
2014
Q2 | $902K | Sell |
|
|||||
|
2014
Q1 | $1.33M | Buy |
|
|||||
|
2013
Q4 | $1.08M | Sell |
|
|||||
|
2013
Q3 | $1.36M | Buy |
|
|||||
|
2013
Q2 | $958K | Buy |
|